Navigation Links
US Oncology Named to FORTUNE Magazine's Most Admired Companies List for Third Time
Date:3/12/2009

HOUSTON, March 12 /PRNewswire/ -- US Oncology, Inc., one of the nation's largest cancer care services companies, has been named to FORTUNE magazine's Most Admired Companies list for 2009. The company ranks third in the Health Care: Pharmacy and Other category. This is the third time US Oncology has been honored with FORTUNE magazine's Most Admired Companies distinction, having been named to the list in 2004 and 2007 in the Diversified Outsourcing Services category.

The magazine's annual list is considered the definitive report card on corporate reputations. Ranked by top industry executives and financial analysts on nine areas of leadership, US Oncology placed third in its sector in the categories of:

  • Innovation
  • People management
  • Use of corporate assets
  • Social responsibility
  • Quality of product/services

The company ranks in the top five of all nine categories, including quality of management, financial soundness (ranked 4), long-term investment and global competitiveness (ranked 5).

US Oncology collaborates with providers, payers, biotech/pharmaceutical and medical equipment manufacturers to increase patient access to advanced cancer care. Recent innovation at US Oncology includes:

  • Innovent Oncology and Level I Pathways: payers and providers working together to give patients the highest quality care possible at more predictable costs. Using evidence-based treatment guidelines, disease man
    '/>"/>

SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Campbell Alliance Brand Management Practice to Present at EyeForPharmas Oncology Summit USA and Oncology Market Access Europe Conference
2. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
3. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
4. Pharmatech 2.0: Introducing Pharmatech Oncology
5. Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting
6. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
7. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
8. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
9. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
10. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
11. First Coast Oncology to Offer Next Generation Proton Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... May 21, 2012   Cord Blood America, Inc ... CBAI ), the umbilical cord blood stem cell ... potential of stem cells to families nationwide and internationally, ... 2012 increased by 6.7%  to $1.55 million compared to ... announced a gross profit of $1.12 million in the ...
(Date:5/21/2012)... 2012  HistoRx, the leader in quantitative ... AQUA technology to assessment of messenger RNA ... and standardization of protein in tissue specimens; ... beyond protein expression analysis to quantification of ... was invented to address the challenges of ...
(Date:5/21/2012)... 21, 2012 International scientific and ... to discuss the potential use of Oxitec,s genetically modified ... combat Dengue Fever in Panama. The independent ... (STRI), The Gorgas Memorial Institute for Health Studies and ... regional experts from these institutes as well as the ...
(Date:5/21/2012)... 21, 2012  Neuralstem, Inc. (NYSE MKT: CUR) ... present at the World Stem Cells & Regenerative ... Tuesday, May 22nd at 12:30 PM. Mr. Garr,s ... review Neuralstem,s cellular therapy trial in ALS, its ... (MDD), and provide an overview on plans to ...
Breaking Biology Technology:Cord Blood America Announces First Quarter Financial Results 2Cord Blood America Announces First Quarter Financial Results 3AQUA® Technology Uses Extend Beyond Protein: Effective measurement of messenger RNA now demonstrated 2AQUA® Technology Uses Extend Beyond Protein: Effective measurement of messenger RNA now demonstrated 3Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 2Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 3Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London 2
... & Associates is launching Prospera , an ... more than 13,000 human resources professionals, the company announced ... five areas of concern for human resources staffs: plan, ... those areas affect a company's bottom line; then it ...
... -- Rita Colwell, former director of the National ... Human Health" at 5:30 p.m. Monday, Oct. 3, in ... Memorial Union. , ,Colwell headed the NSF from 1998-2004. ... is a distinguished professor at the University of Maryland ...
... provider IDX Systems Corp. , of Burlington, Vt., ... expected to close by early 2006. , ,"Both GE ... GE Healthcare Vice President Don Woodlock. "What we can ... radiology systems, across electronic health records, both in-patient and ...
Other Biology Technology:J.J. Keller, Modine Manufacturing, Gustave A. Larson Co., Esker, Firstlogic, Software One 2
(Date:5/21/2012)... , , , , , ... , , , , ... industrial chemicals and human health are a step closer thanks to breakthrough research by CSIRO researchers who have supercharged safflower to produce increased amounts... , ... , , , , ... , , , , , ...
(Date:5/20/2012)... histone de-acetylase (HDAC) inhibitor panobinostat is able to ... a new study published in BioMed Central,s open ... from Tulane University Health Sciences Center have shown ... cells and reduce tumor growth in mice. , ... diagnosis to be triple negative. These aggressive tumours ...
(Date:5/20/2012)... and Cancer Research Group headed by Dr Hctor ... Oncology (VHIO) has identified the molecular mechanisms that ... clinical trials for colon cancer treatment. The study ... with Professor Alberto Muozs laboratory at the Instituto ... Investigaciones Cientficas (IIB-CSIC-Madrid). Published today in Nature ...
Breaking Biology News(10 mins):Supercharged safflower 2Supercharged safflower 3Supercharged safflower 4Blocking DNA: HDAC inhibitor targets triple negative breast cancer 2Discovery of mechanisms predicting response to new treatments in colon cancer 2Discovery of mechanisms predicting response to new treatments in colon cancer 3Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee 74484 1Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee 74484 2Who Doesn 26apos 3Bt Love Free 3F 74480 1Who Doesn 26apos 3Bt Love Free 3F 74480 2Cardium Regains Listing Compliance With NYSE Amex 16849 1Cardium Regains Listing Compliance With NYSE Amex 16849 2Cardium Regains Listing Compliance With NYSE Amex 16849 3Cardium Regains Listing Compliance With NYSE Amex 16849 4
... of Texas Medical School at Houston could help experts better ... during their second pregnancies for a common bacterial infection if ... B Streptococcus, or GBS, is a type of bacterial infection ... be deadly to an infant passing through the mother,s birth ...
... have found a way to pull pure oxygen from ... and a room-temperature glass of water. ,Because oxygen ... using solar electricity to split water into those elements--a ... One of the chief obstacles to that green-energy scenario ...
... of Energy (DOE) Under Secretary for Science Dr. Raymond ... Education and Economics Gale Buchanan today announced plans to ... accelerate fundamental research in the development of cellulosic biofuels. ... best near- to mid-term alternatives we have, on the ...
Other Biology News:Recurrence of group B strep high in subsequent pregnancies, say UT Houston obstetricians 2Water refineries? 2Water refineries? 3DOE and USDA announce more than $10 million in bioenergy plant feedstock research 2
Request Info...
Ultra-sensitive, non-radioactive detection of Protein G. Measure Protein G levels quickly and easily....
Request Info...
TRIS-EDTA based buffer prepared from RNase-free water suitable for storage and dilution of siRNA, pH 8, store at 4 C ...
Biology Products: